Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

VTE Risk Assessment and Prophylaxis: The Reliability of Clinical Assessment by Medical Housestaff,

Monica Reddy Muppidi, MD, Ashima Sahni, MD, Abhimanyu Saini, MD, Samrat Khanna, MD, Larissa Verda, MD, PhD, William Trick, MD, Shane Borkowsky, MD, Shweta Gupta, MD, Krishna Das, MD

Blood (2011) 118 (21): 4199.

https://doi.org/10.1182/blood.V118.21.4199.4199

Published: 2011

Journal Articles

Autologous Non-Myeloablative Hematopoietic Stem Cell Transplantation for Refractory Systemic Vasculitis.

Laisvyde Statkute, MD, Yu Oyama, MD, Walter G. Barr, MD, Jolita Satkus, MD, Yvonne Loh, MD, Larissa Verda, MD, PhD, Richard K. Burt, MD

Blood (2006) 108 (11): 5457.

https://doi.org/10.1182/blood.V108.11.5457.5457

Published: 2006

Journal Articles

Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Relapsing-Remitting Multiple Sclerosis.

Richard K. Burt, MD, Yu Oyama, MD, Laisvyde Statkute, MD, Kathleen Quigley, RN, Catherine Weppner, RN, Larissa Verda, MD, PhD

Blood (2005) 106 (11): 2930.

https://doi.org/10.1182/blood.V106.11.2930.2930

Published: 2005

Journal Articles

Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus.

Laisvyde Statkute, MD, Yu Oyama, MD, Ann Traynor, MD, Larissa Verda, MD, PhD, Walter G. Barr, MD, Robert Rosa, MD, James Schroeder, MD, Nela Krosnjar, MD, Kathleen Quigley, RN, Kimberly Yaung, RN, Marcelo Villa, Miyuki Takahashi, MD, Richard K. Burt, MD

Blood (2005) 106 (11): 156.

https://doi.org/10.1182/blood.V106.11.156.156

Published: 2005

Journal Articles

Mobilization, Harvesting and Selection of Peripheral Blood Stem Cells in Patients with Autoimmune Diseases Undergoing Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation.

Laisvyde Statkute, MD, Larissa Verda, MD, PhD, Yu Oyama, MD, Marcelo Villa, Thomas Shook, Ronnie Clifton, Nela Krosnjar, MD, Kathleen Quigley, RN, Kimberly Yaung, RN, Catherine Weppner, RN, Richard K. Burt, MD

Blood (2005) 106 (11): 1980.

https://doi.org/10.1182/blood.V106.11.1980.1980

Published: 2005

Journal Articles

Restoration of the CD4+CD25 bright Regulatory Cell Subset in Patients with Crohn’s Disease Following Autologous Non-Myeloablative Stem Cell Transplantation (NST).

Larissa Verda, MD, PhD, Yu Oyama, MD, Robert Craig, MD, Laisvyde Statkute, MD, Nela Krosnjar, MD, Kathleen Quigley, RN, Richard K. Burt, MD

Blood (2005) 106 (11): 2193.

https://doi.org/10.1182/blood.V106.11.2193.2193

Published: 2005

Journal Articles

An Edible, High Molecular Weight Glycoprotein Fraction from Ganoderma Lucidum Inhibits the Akt Pathway in Resistant Myeloma Cell Lines Decreasing Mcl-1 Expression, Up-Regulating FKHR and Inducing Apoptosis.

Nazneen Sultana, MD, Larissa Verda, MD, Richard K. Burt, MD, Ann E. Traynor, MD

Blood (2004) 104 (11): 4895.

https://doi.org/10.1182/blood.V104.11.4895.4895

Published: 2004

NARROW

VTE Risk Assessment and Prophylaxis: The Reliability of Clinical Assessment by Medical Housestaff,

Autologous Non-Myeloablative Hematopoietic Stem Cell Transplantation for Refractory Systemic Vasculitis.

Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Relapsing-Remitting Multiple Sclerosis.

Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus.

Mobilization, Harvesting and Selection of Peripheral Blood Stem Cells in Patients with Autoimmune Diseases Undergoing Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation.

Restoration of the CD4+CD25 bright Regulatory Cell Subset in Patients with Crohn’s Disease Following Autologous Non-Myeloablative Stem Cell Transplantation (NST).

An Edible, High Molecular Weight Glycoprotein Fraction from Ganoderma Lucidum Inhibits the Akt Pathway in Resistant Myeloma Cell Lines Decreasing Mcl-1 Expression, Up-Regulating FKHR and Inducing Apoptosis.

Email alerts

ASH Publications

American Society of Hematology

VTE Risk Assessment and Prophylaxis: The Reliability of Clinical Assessment by Medical Housestaff,

Autologous Non-Myeloablative Hematopoietic Stem Cell Transplantation for Refractory Systemic Vasculitis.

Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Relapsing-Remitting Multiple Sclerosis.

Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus.

Mobilization, Harvesting and Selection of Peripheral Blood Stem Cells in Patients with Autoimmune Diseases Undergoing Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation.

Restoration of the CD4+CD25 bright Regulatory Cell Subset in Patients with Crohn’s Disease Following Autologous Non-Myeloablative Stem Cell Transplantation (NST).

An Edible, High Molecular Weight Glycoprotein Fraction from Ganoderma Lucidum Inhibits the Akt Pathway in Resistant Myeloma Cell Lines Decreasing Mcl-1 Expression, Up-Regulating FKHR and Inducing Apoptosis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only